We have created embryonic stem (ES) cells and mice lacking the predominant isoform (or) of the calcineurin A subunit (CNAc~) to study the role of this serine/threonine phosphatase in the immune system. T and B cell maturation appeared to be normal in CNAct -/-mice. CNAc~ -/-T cells responded normally to mitogenic stimulation (i.e., PMA plus ionomycin, concanavalin A, and anti-CD3e antibody). However, CNAot -/-mice generated defective antigen-specific T cell responses in vivo. Mice produced from CNAot -/-ES cells injected into RAG-2-deficient blastocysts had a similar defective T cell response, indicating that CNAot is required for T cell function per se, rather than for an activity of other cell types involved in the immune response. CNAoL -/-T cells remained sensitive to both cyclosporin A and FK506, suggesting that CNA[3 or another CNA-hke molecule can mediate the action of these immunosuppressive drugs. CNAc, -/-mice provide an animal model for dissecting the physiologic functions of calcineurin as well as the effects of FK506 and CsA.
C
alcineurin, also known as protein phosphatase 2B, is a calcium-and calmodulin-dependent serine/threonine protein phosphatase (1, 2) . It is expressed in all mammalian tissues examined and is most abundant in the brain (2) . In lymphocytes, calcineurin is the major soluble calmodulinbinding protein (3) . Calcineurin is a heterodimer consisting of a catalytic subunit (CNA1; 61 kD) and a regulatory subunit (CNB; 19 kD). The phosphatase activity of the A subunit is regulated by calcium through both calmodulin and the B subunit (4) . There are two genes encoding closely related (N80% identical) CNA subunit isoforms, CNAcx and CNA [3, in the mouse, human, and rat genomes (5-8 and our unpublished data). The r isoform is the predominant isoform found in brain, thymus, and T cells (1, 9, 10 , and our unpublished data). Even though CNAcx and CNA [3 1Abbreviations used in this paper: CNA, A subunit of calcineurin; CNAa, CNA[3, isoforms of CNA; EF, embryonic fibroblast cells; ES, embryonic stem cells; ne0, neomycin phosphotransferase gene; tk, thyrmffme kinase gene.
have similar functions in vitro, the physiologic functions of the different calcineurin A isoforms are not yet defined.
CsA and FK506 are immunosuppressive drugs used to prevent graft rejection after organ transplantation. In vitro studies from several groups have suggested that CsA and FK506 exert their immunosuppressive effects by inhibiting calcineurin's phosphatase activity (11) (12) (13) (14) (15) . Complexes formed by CsA and FK506 and their respective binding proteins inhibit calcineurin's phosphatase activity (16) (17) (18) . This loss of phosphatase activity correlates with inhibition ofT cell activation (19) .
To distinguish the roles of CNAcr and CNA[3 in T cell activation, we generated embryonic stern (ES) cells and mice lacking a functional CNAa gene. The composition and distribution ofT cell subsets were normal in CNAcx -/-mice. CNAcr -/-and wild-type T cells displayed similar responses to mitogenic stimulation. Surprisingly, CNAc~ -/-mice gave deficient in vivo antigen-specific T cell responses. The residual CNA[3 activity in CNAcx -/-T cells cannot substitute for CNAot activity in the immune response. CNAc~ -/-T cells remained sensitive to CsA and FK506, suggesting that another molecule, probably CNA~3, can mediate the action of CsA and FK506 in T cells.
Materials and Methods
Construction of Targeting Vectors. The targeting construct used to disrupt the CNAc~ gene was designed for implementing the double-selection technique previously described (20, 21) . Murine CNA(x cDNA was cloned by PCR. amplification (22) from mouse brain total cDNA using primers corresponding to CNAoL cDNA sequence (reference 8; GenBank accession No. J05479). The murine CNAo~ cDNA was used to screen a 129/SVJ liver genomic library (Stratagene, La Jolla, CA). A bacteriophage clone encoding part of the CNAot catalytic domain (8) was isolated and designated MCAL-1. A 13-kb EcoRI fragment from clone MCAL-1 was subcloned into Bluescript containing the thymidine kinase gene (tk) (21) . The intron-exon boundaries of this genomic fragment were defined by restriction enzyme site mapping and nucleotide sequence analysis (22) . The neomycin phosphotransferase gene (neo) was inserted into an MluI site in the exon encoding nucleotides 572-717 of the mouse CNAot mRNA sequence (8) . Both neo and tk were under the control of the phosphoglycerate kinase promoter.
Transfection and Selection of Mutant ES Cells. J1 ES cells were grown on feeder layers of ~-irradiated embryonic fibroblast (EF) cells as described (23). 1.5-2 • 107 J1 cells at passage 9-10 were trypsinized and resuspended in 1 ml ofelectroporation buffer (24) that had been modified to contain 137 mM NaC1. 50 I~g of construct DNA was introduced into J1 ES cells by electroporation. The ES cells were then grown in G418 and 1-[2-deory,2-fluorobeta-D arabinofuranosyl]-5-ioduracil (FIAU) as described previously (23) . Surviving clones were picked 8-10 d after selection, and DNA was extracted for Southern blot analysis.
Generation of Germline Chimeras. Heterozygous ES cells were injected into C57BL/6J blastocysts and reimplanted into the uteri of Black Swiss pseudo pregnant female mice as described (25) . Agouti male offspring (derived from the 129 ES cells) were mated to Black Swiss or C57BL/6J females. Germline transmission of the mutated allele of the CNAo~ gene was monitored by Southern blot analysis of tail DNA from the agouti F1 offspring (see Fig. 1 ). Homozygous CNAot /-mice were obtained by mating the heterozygous CNAo~ +/-mice. The mice used in the experiments presented here were 8-10 wk old, of either Black Swiss/129 background or ofB6/129 background, as noted.
Generation of CNA~-/-ES Cells and CNAo~ -/ ~RAG-2 -lChimeras.
Homozygous mutant ES cells were generated from heterozygous CNAot +/-ES cells as described (21) with the following modification: 1-2 • 106 heterozygous knockout ES cells from a single clone were plated onto each 10-cm plate on G418-resistant EF cells in leukemia inhibitory factor (LIF)-supplemented (1,000 U/ml) media. After 12 h, 1.5 p,g dry powder G418 was added per milliliter of culture. After 4-6 d of G418 selection, surviving colonies were picked and the structure of the CNAol gene was assessed by Southern blot analysis.
CNA~x -/-ES cells were injected into RAG-2 -/-blastocysts (26) of either B6/129 or FvB background to generate somatic chimeras (27) . The ES cell contribution to the chimera was assessed by coat color (for mice bred into the FvB background), and by quantification of peripheral blood CD4 + and CD8 + lymphocytes. Chimeras used in experiments were 10 wk old.
CytofluorometricAnalyses. The thymus, lymph nodes, and spleen were isolated from wild-type, CNAot -/-, and CNAot-/-/ RAG-2 -/-mice, and tissues were dissociated into single-cell suspensions. RBC were lysed by the addition of 1-5 rnl of Tris/ NH4C1 solution for 5 min at room temperature. Cell suspensions were filtered with a nylon mesh and washed twice with staining medium (HBSS with reduced phenol red, sodium azide, BSA, and EDTA). 0.5 • 106 cells were resuspended in 25 p~l staining medium and incubated for 15 rain on ice with 1 p,g of PE-or FITC-labeled antibodies (PharMingen, San Diego, CA) in 10 p2 staining medium. Cells were washed once and fixed with 0.5% formamide in staining medium. Flow cytometry was carried out using a flow cytometer (Cytofluorograf IIs; Becton-Dickinson, San Jose, CA). Each analysis recorded 20,000 cells.
H-2 Genotyping. The presence of H-2 b alleles in the wildtype and CNA~t -/-mice of Black Swiss/129 background was ascertained by PC1L amplification of an l-E(x b fragment (28) using the following primers: E~5' (AGTCTTCCCAGCCTTCAC-ACTCAGAGGTAC) and E,~3' (CATAGCCCCAAATGTCTG-ACCTCTGGAGAG) (28a).
In Vivo Immunization and In Vitro T Cell Proliferation and Cytokine Production Assays. 8-10-wk-old wild-type and CNA~ -/-mice of Black Swiss/129 background were immunized with 300 txg of trinitrophenol (TNP)-conjugated OVA in CFA via foot pad injection (29) . 10 d after immunization, lymph node cells were harvested. 2 • 10 s lymph node cells per well were cultured in triplicates in 96-well plates containing OVA alone, OVA plus 2 • 10 s T cell-depleted and irradiated C57BL/6 spleen cells (as sources of exogenous APCs), or with OVA plus 10 U/ml IL-2. 60 h after stimulation, 1 b~Ci [3H]thymidine was added per well, and incorporated radioactivity was assayed 6 h later.
T cell-derived cytokines were measured using standard procedures (30) To assay polyclonal T cell responses, spleen and lymph node cells from wild-type and CNAo~ -/ mice of Black Swiss/129 background were harvested and cultured in duplicates at 2 • l0 s cells/well with 2.5 ng/ml PMA plus 75 ng/ml ionomycin, or 2.5 p~g/ml ConA, or soluble oLCD3e antibody (1:500 dilution of 145.2C11 hybridoma supematant) (sCD3), or plate-bound o~CD3e antibody (plate coated with 10 I~g/ml of purified c~CD3e antibody) (x-CD3). After 60 h of stimulation, cultures were pulsed with 1 b~Ci/well [3H]thymidine for 6 h.
Assessment of Calcineurin in T Cells. Spleen and lymph nodes harvested from wild-type and CNAc~ -/-mice were dispersed into single-cell suspensions. Pd3C were removed by lysis (see above). The cell concentrations were adjusted to 1.5-2.0 • 10 ~ in 2 ml of PBS containing 5% FCS and 4 mM EDTA. The cell suspensions were enriched for T ceils using Mouse T Cell Enrichment Columns (R&D Systems, Inc., Minneapolis, MN). The T cells were lysed in buffer containing 50 mM Tris-HC1, pH 7.5, 15% glycerol, 0.1 mM EGTA, 1 mM EDTA, 0.5 mM DTT, 50 p~g/ml PMSF, 50 p,g/ml soybean trypsin inhibitor, 5 p,g/ml aprotinin, and 5 ~g/ml leupeptin. Aliquots of 8 • 106 cells/50 p~l oflysis buffer were frozen until further analysis.
The amount of calcineurin Ao~ in T cell extracts was assessed by Western blots (31) . 20 I~g of T cell extract were fractionated by SDS-PAGE on a 16% Tris/glycine gel (Novex, San Diego, CA) at 150 V (constant voltage) and transferred to a polyvinyldifluoride membrane (Immobilon) at 100 V for 1.5 h. After transfer, the membrane was blocked overnight in M-Blotto at 4~ The membranes were briefly rinsed in PBS and reacted with either rabbit antibody R2929 (specific for COOH-terminal peptide, SNSSNIQ from human CNAcx) or rabbit antibody R2948 (specific for CNA[3 residues 386-396, LMTEGEDEFDG). Rabbit antipeptide antiserum was diluted to 1:10,000. The membranes were washed and HPR-conjugated donkey anti-rabbit secondary antibody diluted 1:10,000 (Amersham Corp., Arlington Heights, IL). The membranes were washed in Tris-buffered saline Tween (TBST) and developed with the enhanced chemiluminescence Western blotting detection system (Amersham).
Calcineurin Phosphatase Assay. The phosphatase assay was as described in Martin and Wiederrecht (32) .
Results
Generation of CNAee -/ -Mice. Calcineurin A0t k n o c kout (CNAoe -/ -) mice were produced by standard methods (25) after homologous recombination in ES cells. T h e gene targeting vector was constructed by inserting the neo gene into an exon that encodes part o f the calcineurin catalytic domain and by inserting the tk gene outside the region of h o m o l o g y (Fig. 1 a) . Linearized construct D N A was transfected into J1 ES cells and colonies were selected for n e om y c i n and F I A U resistance (21, 23) . D N A from individual clones was analyzed by Southern blot analysis after digestion with MscI and hybridization with the 1.2-kb probe (Fig. 1) . A novel 7.5-kb fragment, as well as the 18-kb fragment found in wild-type ES cell D N A , were found in CNAo~ +/-ES cell D N A (Fig. 1 b; data n o t shown) .
Heterozygous CNA0t +/-ES cells were then injected into C 5 7 B L / 6 blastocysts and some o f the resultant chimeric mice passed the mutated gene onto the next generation w h e n mated with Black Swiss or C 5 7 B L / 6 mice. CNAcx -/ -mice were obtained by mating the heterozygous CNA~x +/-mice.
Generation of C N A a -/ -/ R A G -2 -/ -Chimeras. CNAcx +/-ES cells were g r o w n in 1.5 m g / m l G418 to select ES cells lacking both copies of functional CNAot genes (21) . D N A was extracted from surviving clones and analyzed by Southern analysis. CNAot -/ -clones were identified by their lack of the endogenous 18-kb MscI fragment ( Fig. 1 b  and data not shown) . T h e functional disruption of the CNA~x gene was confirmed by lack o f C N A a expression in CNA~x -/ -ES cells. R N A from wild-type, CNAo~ +/-, and CNAoL -/ -ES cells were characterized by N o r t h e r n blot analysis using the 5' end of CNAo~ c D N A (reference 8; nucleotides 95-714) as probe. CNAot mP,.NA was detected in wild-type ES cells and in CNAcx +/-ES cells, b u t n o t in CNAoL -/ -ES cells (Fig. 1 c) .
CNAcx -/ -ES cells were injected into R A G -2 -/ -blastocysts of either B 6 / 1 2 9 or FvB background to generate somatic chimeras (27) . In R A G -2 -/ -mice, there are no m ature T and B cells because of the inability of their Ig or TCR. genes to undergo rearrangement (26) . Therefore, all the mature T and B cells in the C N A c i -/ -/ R A G -2 -/ -chimeras should be derived from the injected CNAot -/ -ES cells. Cakineurin Activity in CNAce -/-T Cells. The amounts of calcineurin in T cell extracts derived from CNAIx -/-and wild-type mice were compared by Western blotting and enzyme activity assays. A CNAoe-specific antibody only detected CNAo~ polypeptide in wild-type T cell extracts, but not in CNAo~ -/-T cell extracts (Fig. 1 d) . A CNAI3-specific antibody did not detect CNA[3 peptide in either wildtype or mutant T cells, even though this peptide could be readily detected in brain (our unpublished results).
Calcineurin activity (okadaic acid resistant and EGTAsensitive phosphatase activity) was measured in the same wild-type and CNAo~ -/-T cell extracts (32) . The phosphatase activity in CNAot -/-T cell extracts was 34% of the activity found in wild-type T cell extracts (169 + 32 vs 500 + 77 pmol substrate/min per mg protein). The residual calcineurin-like activity in the mutant T cells could be contributed by other calcineurin isoforms or by other related phosphatases. The phosphatase activity in both the wild-type and CNA~x -/-T cells was 90-95% inhibited by FK506. Our data, consistent with previous findings, suggested that o~ is the predominant isoform in T cells. In the absence of CNAoq CNA[3 does not seem to be increased 9 After restimulation in vitro with OVA, T ceils from wild-type mice proliferated much more rapidly than T cells from CNAcx -/ -mice (Fig.  3 a; data not shown). Addition of normal APCs or IL-2 to the in vitro cultures did not complement the proliferative defect ofCNA~x -/ -T cells (Fig. 3 a) .
The defect in the antigen-specific T cell response could be caused either by a defect in CNAo~ -/ -T cells or by a defect in other cells whose function is required for the priming of antigen-specific T cells as a result o f immunization. To distinguish between the two possibilities, we immunized C N A o~-/ -/ R A G -2 -/ -chimeras with T N P -O V A and restimulated the lymph node cells with the i m m u n ogen after 10 d. CNAo~ -/ -T cells from the C N A o~-/ -/ R A G -2 -/ -chimeras did not proliferate as well in response to O V A (Fig. 3 b) . In the C N A o L -/ -/ R A G -2 -/ -chimeras, only T and B cells were completely CNAcx -/ -, while 90% o f other cell types were derived from the R A G -2 -/ -blastocysts that were C N A a +/+, because the CNAcx -/ -E Sderived cells comprised only ~1 0 % of the chimeric animals, as judged by coat color contributions. This suggested that the defective in vivo antigen-specific T cell response in CNAcx -/ -mice was caused by deficits in T cells per se, rather than deficits in any other cell types involved in the initiation o f immune response.
U p o n restimulation with OVA, the lymph node T cells from immunized CNAcx -/ -mice secreted significantly less IL-2, IL-4, and IFN-'y than the lymph node T cells from immunized normal mice (Table 1) . Primary antibody responses were also assessed in wild-type and CNAoL -/ -mice immunized with T N P -O V A . Similar titers o f a n t i -T N P antibodies (IgG1 and IgG2a) were found in the serum o f immunized wild-type and CNAcx -/ -mice (data not shown). CsA and FK506 . W e tested the responses o f wild-type and CNAo~ -/ -T cells to mitogenic stimulation with P M A plus ionomycin, ConA, and antiCD3e antibodies. All three mitogens induced the CNAc~ -/ - T cells to proliferate as rapidly as the wild-type T cells (Fig.  4) . Furthermore, stimulated mutant and wild-type T cells produced the same amounts o f l L -2 and IL-4 and expressed normal level of IL-2II, on the cell surface (data not shown). Nuclear factor of activated T cells (NF-AT) was also translocated into the nucleus after mitogen stimulation (data not shown). Thus, CNAcx -/ -T cells appeared to be functional when stimulated by polyclonal mitogens in vitro. Calcineurin, especially calcineurin containing the A s subunit, has been implicated as the target for the i m m u n osuppressive drugs CsA and FK506, which inhibit T C Rmediated proliferation and IL-2 production by normal T cells (33) (34) (35) (36) . W e tested the drug sensitivity o f the C N A a -/ -T cells. Cell proliferation and IL-2 and IL-4 production were inhibited in CNA~x -/ -and wild-type T cells stimulated with PMA plus ionomycin, ConA, or 0tCD3e antibody, CNAot -/-T cells, and wild-type T cells were both inhibited by CsA and FK506, as measured by proliferation and by IL-2 and IL-4 production ( Fig. 5 ; data not shown). CNAot -/-T cells were even more sensitive to these drugs than normal T cells, with a ICs0 two-to sevenfold lower than that of the wild-type T cells.
C N A a -/ -T Cells Respond Normally to Mitogens In Vitro and Remain Sensitive to

Discussion
We have generated mice that lack CNAot by inactivating the CNAoe gene (Fig. 1) . We demonstrate here that there was >65% reduction ofcalcineurin activity in the CNAot -/-T lymphocytes. The residual calcineurin-like activity in the mutant T cells is likely to be contributed by other calcineurin isoforms or by other related phosphatases. Our data suggest, however, that 0t is the predominant isoform in T cells; in the absence of CNAot, expression of CNA[3 is not increased (data not shown). T and B cell development appears to proceed normally in CNAot -/-mice ( Fig. 2; data not shown), indicating that a functional CNAoe gene is not required for the maturation of these cells. The mutant mice have a defective T cell response to antigen in vivo. Because this defective T cell response could not be complemented by other cells supplied by RAG-2 /-mice, we conclude that CNAot is required for in vivo antigen-specific T cell responses.
Even though CNAc~ is required for in vivo T cell response, it is not required for in vitro T cell responses to mitogens ( Fig. 3 and 4 ; data not shown). This result contrasts with previous findings implicating CNAot in TCR-mediated proliferation and IL-2 production (33-36). We do not know the reason for the discrepancy, but our findings do suggest that in vitro T cell responses to otCD3e antibody or ConA may not reflect the ability of T cells to respond to antigens in vivo.
CNAot -/-T cells were sensitive to FK506 and CsA ( Fig. 5 ; data not shown) suggesting that other molecules can mediate the immunosuppressive effect of these drugs. One of these proteins is most likely to be CNA[3. When CNA[3 is over expressed in Jurkat cells, it has the same biological activities as over-expressed CNAot (O'Keefe, S.J., unpubhshed results). Furthermore, 90-95% of the residual calcineurin activity found in CNAc~ -/-T cells, which is most likely contributed by CNAJ], is FKS06 sensitive. Both of these observations suggest that CNA[3 can serve as an immunosuppressive drug target in the CNAot -/-T cells. We cannot, however, rule out the possibility that there are other drug targets, since CsA and FK506 were shown to inhibit an antigen-specific response in the absence of a calcium signal (37) . CNA~t -/-T cells had increased sensitivity to both CsA and FK506, suggesting that CNAot is the primary target of drug-immunophilin complexes, presumably because of the predominant presence of the CNAot protein in T cells.
The finding that CNA0t -/-nfice have a marked T cell deficiency suggests that CNAcx may be a relevant calcineurin, isoform that mediates immunosuppression after treatment with CsA or FK506. We suggest that CsA and FKS06 also target other proteins, which are sufficient to mediate the in vitro T cell responses to mitogens. However, these other CsA and FK506 target proteins cannot replace CNAct's function in vivo. Furthermore, studies of CNAot -/-mice should elucidate other roles for CNAcx in physiology and pathobiology. lymph node cells were stimulated with 10 ng/ml PMA + 300 ng/ml ionomycin in the presence of different concentrations of CsA (a) or FK506 (b). 60 h after stimulation, cultures were pulsed with [3Hlthymidine for 6 h. Experiments were done in triplicate.
